Purchase Order N3239826P0103

The Bureau of Medicine and Surgery issued a delivery order to Roche Diagnostics Corporation on March 10, 2026, with a ceiling value of $826,390.04 and an ultimate completion date of April 13, 2026. The order is firm fixed price and was issued without set-aside. Place of performance is Castleton, IN 46256. The delivery order calls for diagnostic equipment, reagents, and associated medical products and services consistent with Roche Diagnostics' portfolio of in vitro diagnostics and laboratory...

<p>The Naval Medical Research Command (Bureau of Medicine and Surgery) awarded a purchase order to Life Technologies Corporation for $6,072.57 on April 11, 2026, with completion by April 10, 2027. The order is firm fixed price with no set-aside applied. Performance takes place at Silver Spring, Maryland. The source does not specify the goods or services procured.</p>

This is a $52,920.00 firm fixed-price purchase order contract awarded by the United States Department of the Naval Medical Research Command (NMRC) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The contract is for a drop shipment of specialized laboratory supplies, including extraction reagents for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, and Influenza A/H5 and Influenza A/H7 diagnostic testing. The supplies are needed by the...

<p>The Naval Medical Research Command, Bureau of Medicine and Surgery, awarded a purchase order to Agilent Technologies Inc. on March 6, 2026, for $11,894.40, with a completion date of March 5, 2029. Place of performance is Silver Spring, Maryland. The order is firm fixed price with no set-aside category. The source does not specify the nature of goods or services being procured under this purchase order.</p>

<p>The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $403,520.60 firm fixed price delivery order for supplies at the Walter Reed Army Institute of Research (WRAIR) in Takoma Park, Maryland. Roche Diagnostics Corporation will provide medical supplies to WRAIR from July 20, 2023 through August 28, 2023 as the prime contractor for this order. No applicable subcontractors were identified in the award information.</p>

The U.S. Navy's Bureau of Medicine and Surgery awarded a $1.0 million firm fixed-price delivery order to Roche Diagnostics Corporation on September 29, 2023, with an ultimate completion date of September 30, 2024. This child delivery order, which carries no set-aside designation, reflects open competition and is performed at Roche's facility in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostics,...

<p>The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $540,000 firm fixed price blanket purchase agreement call contract to provide medical supplies and reagents such as COBAS OMNI processing plates, COBAS 6800/8800 SPEC diluent reagents, and COBAS PCR urine test kits. The place of performance will be Roche Diagnostics' facility located in Bethesda, Maryland. The period of performance is from February 23, 2022 through October 22, 2022.</p>

The Naval Medical Research Command (NMRC), through the Bureau of Medicine and Surgery (a Defense agency), awarded a $237,668.88 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 9, 2024, for continued service maintenance of three 7500 FAST DX polymerase chain reaction (PCR) instruments. The contract, which extends through December 30, 2029, supports the Molecular Diagnostics Department of NMRC's Biological Defense Research...

Roche Diagnostics Corporation was awarded a $103,000 firm fixed price purchase order by the Department of the Army Medical Command to supply anti SARS COV products. The place of performance is Fort Liberty, NC and the completion date is September 30, 2020. The award is associated with the national interest action code for coronavirus COVID-19 response efforts. Roche, a foreign owned for-profit manufacturer of medical devices and supplies, will deliver the requested anti viral testing systems and...

The Department of the Navy's Bureau of Medicine and Surgery awarded a purchase order to Biofire Defense LLC on March 5, 2026, for in-vitro diagnostic substances, reagents, and test kits, with a ceiling value of $45,128.56. The order carries no set-aside designation and procures 3,000 units of Buffer 10X with BSA-50mM MgCL2 with orange cap under FAR Part 12 commercial item procedures. Performance is located in Frederick, Maryland. The order is due for completion by July 31, 2026, and originated...